These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15735062)

  • 21. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
    Chaudhary NI; Roth GJ; Hilberg F; Müller-Quernheim J; Prasse A; Zissel G; Schnapp A; Park JE
    Eur Respir J; 2007 May; 29(5):976-85. PubMed ID: 17301095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
    van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
    J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis.
    Krishna G; Liu K; Shigemitsu H; Gao M; Raffin TA; Rosen GD
    Am J Pathol; 2001 Mar; 158(3):997-1004. PubMed ID: 11238047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.
    Fabre A; Marchal-Sommé J; Marchand-Adam S; Quesnel C; Borie R; Dehoux M; Ruffié C; Callebert J; Launay JM; Hénin D; Soler P; Crestani B
    Eur Respir J; 2008 Aug; 32(2):426-36. PubMed ID: 18321937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
    J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Imatinib].
    Urabe A
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1191-6. PubMed ID: 12938280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gefitinib prevents bleomycin-induced lung fibrosis in mice.
    Ishii Y; Fujimoto S; Fukuda T
    Am J Respir Crit Care Med; 2006 Sep; 174(5):550-6. PubMed ID: 16741154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.
    Irsan I; Akisue T; Hara H; Fujimoto T; Imabori M; Doita M; Kuroda R; Fujioka H; Kawamoto T; Yamamoto T; Kurosaka M
    Anticancer Res; 2007; 27(1A):423-9. PubMed ID: 17352263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.
    Ogawa Y; Kawamura T; Furuhashi M; Tsukamoto K; Shimada S
    J Dermatol Sci; 2008 Sep; 51(3):190-9. PubMed ID: 18485676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice.
    Nakagawa H; Takiguchi T; Nakamura M; Furuyama A; Koyanagi S; Aramaki H; Higuchi S; Ohdo S
    Biochem Pharmacol; 2006 Nov; 72(10):1237-45. PubMed ID: 16973134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
    Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
    Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM; Broaddus RR; Schmandt R; Wu W; Oh JC; Ramondetta LM; Burke TW; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Oct; 95(1):32-6. PubMed ID: 15385107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
    Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
    Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
    Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.